Note 3 - Pro Forma Financial Information (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Milestone Medical Inc. & Milestone Education LLC [Member] | Pro Forma [Member] | Milestone China [Member]
Income (Loss) from Equity Method Investments				$ (63,979)
Milestone Medical Inc. & Milestone Education LLC [Member] | Pro Forma [Member]
Total revenue				4,590,067
Cost of Goods Sold				1,507,552
Gross Profit				3,082,515
Selling, general and administrative expenses				6,148,121
Research and development expenses				384,752
Operating expenses				6,532,873
Loss from operations				(3,450,358)
Interest income				(3,412)
Total other expenses, net				(3,412)
Loss before provision for income tax and equity in net earnings of equity investments				(3,453,770)
Provision for Income Tax				(13,646)
Loss before equity in net earnings of equity investments				(3,467,416)
Income (Loss) from Equity Method Investments				(63,979)
Net loss				(3,531,395)
Less: Net loss attributable to the noncontrolling interests				(1,038,888)
Net loss attributable to Milestone Scientific Inc.				(2,492,507)
Milestone China [Member]
Income (Loss) from Equity Method Investments	$ (57,882)	$ (160,654)	$ (222,719)	(63,979)
Total revenue	2,371,710	1,766,759	5,836,196	4,536,963
Cost of Goods Sold	789,801	570,729	2,157,990	1,503,877
Gross Profit	1,581,909	1,196,030	3,678,206	3,033,086
Selling, general and administrative expenses	3,290,998	2,590,897	6,292,109	4,488,978
Research and development expenses	309,335	18,820	452,780	28,938
Operating expenses	3,600,333	2,609,717	6,744,889	4,517,916
Loss from operations	(2,018,424)	(1,413,687)	(3,066,683)	(1,484,830)
Total other expenses, net	1,004	1,130	1,936	(80)
Loss before provision for income tax and equity in net earnings of equity investments	(2,019,428)	(1,414,817)	(3,068,619)	(1,484,750)
Provision for Income Tax	16,791	13,646	63,624	13,646
Loss before equity in net earnings of equity investments	(2,036,219)	(1,428,463)	(3,132,243)	(1,498,396)
Income (Loss) from Equity Method Investments	(57,882)	(690,213)	(222,719)	(1,047,914)
Net loss	(2,094,101)	(2,118,676)	(3,354,962)	(2,546,310)
Less: Net loss attributable to the noncontrolling interests	507,262	45,727	976,308	53,987
Net loss attributable to Milestone Scientific Inc.	$ (1,586,839)	$ (2,072,949)	$ (2,378,654)	$ (2,492,323)